Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.

Bing Liu,Jian-Wen Huang,Yong Li,Bao-Shan Hu,Xu He,Wei Zhao,You-Bing Zheng,Ligong Lu

Single-Agent versus Combination Doxorubicin-Based Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Single-Blind, Randomized, Phase II Trial.

2015

Bing Liu
Jian-Wen Huang
Yong Li
Bao-Shan Hu
Xu He
Wei Zhao
You-Bing Zheng
Ligong Lu

Objectives: It was the aim of this study to find an optimal therapeutic regimen of transarterial chemoembolization (TACE) by comparing the efficacy of chemoemboli

Keywords:

Pathology
Regimen
Cancer research
Doxorubicin
Hepatocellular carcinoma
Medicine
Gemcitabine
single blind
Oncology
Internal medicine
single agent
therapeutic regimen

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations